Related Pages for ASTRAL
- Option Chain
- Straddle OC
- Max Pain
- Put Call Ratio
- Option Analytics
- Call OI vs Put OI
- Strike Flow
- Call OI Chg vs Put OI Chg
- Call Vol vs Put Vol
- Buildup & Unwinding
- Vega Divergence
- Multi Strike OI
- Multi Straddle Analysis
- Price vs OI
- Time Series Table
- Time Series Multi Chart
- Volatility Skew
- Premium Decay
- IV - HV
- IV Intraday
- Future Chain
- Future Intraday Analysis
- Technical
- Financials
- Chart
- About
No results found.
ASTRAL
Related News - ASTRAL
Astral: CLSA on Astral Maintains Hold with Target Price of ₹1,490 as piping demand rebounded sharply with 40% July growth after 1Q channel destocking, EBITDA margins improved in piping while adhesives faced high-cost inventory pressure, and maintained guidance remains achievable.
13 Aug 2026 09:04 AM
Astral: CLSA on Astral Maintains Hold with Target Price of ₹1,490 as piping demand rebounded sharply with 40% July growth after 1Q channel destocking, EBITDA margins improved in piping while adhesives faced high-cost inventory pressure, and maintained guidance remains achievable.
Astral: Citi on Astral Maintains Buy with Target Price of ₹1,900 as 1Q EBITDA rose 25% YoY across plumbing and adhesives, piping volumes sharply recovered in July with double-digit FY27 growth, management remains confident on 10-15% volume and 10% value growth, while CPVC backward integration in 4QFY27 should support FY28 margins and market share.
13 Aug 2026 09:04 AM
Astral: Citi on Astral Maintains Buy with Target Price of ₹1,900 as 1Q EBITDA rose 25% YoY across plumbing and adhesives, piping volumes sharply recovered in July with double-digit FY27 growth, management remains confident on 10-15% volume and 10% value growth, while CPVC backward integration in 4QFY27 should support FY28 margins and market share.
Astral: Management Reports 15.9% Growth In Q1 FY27 With 15.5% EBITDA Margin, Confident In Surpassing Annual Growth Guidance Of 20-25%. Plumbing Division Continues With Double-Digit Volume Growth And 16-18% EBITDA Margin Guidance.
13 Aug 2026 08:46 AM
Astral: Management Reports 15.9% Growth In Q1 FY27 With 15.5% EBITDA Margin, Confident In Surpassing Annual Growth Guidance Of 20-25%. Plumbing Division Continues With Double-Digit Volume Growth And 16-18% EBITDA Margin Guidance.
Astral: Adhesive India Aims for 15-20% Growth and 15% EBITDA Margin, While Adhesive UK Seeks Double-Digit Growth (Q1 Was 26%) with 8-10% EBITDA Margin for the Year. The Paint Segment Projects 20-25% Revenue Growth but Lower Single-Digit EBITDA Margin, and Bathware Expects 20-25% CAGR Over the Next 4-5 Years.
13 Aug 2026 08:46 AM
Astral: Adhesive India Aims for 15-20% Growth and 15% EBITDA Margin, While Adhesive UK Seeks Double-Digit Growth (Q1 Was 26%) with 8-10% EBITDA Margin for the Year. The Paint Segment Projects 20-25% Revenue Growth but Lower Single-Digit EBITDA Margin, and Bathware Expects 20-25% CAGR Over the Next 4-5 Years.
Astral: CPVC Resin Plant Set for Completion by Late December, Q4 Trial Runs Planned, PEX-Aluminum-PEX Machines to Start Production by September End; FY27 Capex Budget Estimated at INR 300-350 Crore.
13 Aug 2026 08:46 AM
Astral: CPVC Resin Plant Set for Completion by Late December, Q4 Trial Runs Planned, PEX-Aluminum-PEX Machines to Start Production by September End; FY27 Capex Budget Estimated at INR 300-350 Crore.
Astral: Company Board Pulls Back on Composite Arrangement Plan After Consultant Advises Against It.
29 Jul 2026 07:05 PM
Astral: Company Board Pulls Back on Composite Arrangement Plan After Consultant Advises Against It.
India Restricts High-priced Suspension-grade PVC Resin Imports For 6 Months; Export-oriented Shipments Exempt ( Chemplast Sanmar, DCW , Dcm Shriram , Astral, Prince Pipes , Finolex )
24 Jul 2026 11:13 AM
India Restricts High-priced Suspension-grade PVC Resin Imports For 6 Months; Export-oriented Shipments Exempt ( Chemplast Sanmar, DCW , Dcm Shriram , Astral, Prince Pipes , Finolex )
Astral: JPMorgan on Astral Downgrade to Neutral, citing demerger uncertainty despite freeing the high-margin plumbing business for stronger capital allocation, potential pressure on paints & adhesives growth, near-term PVC price correction, inventory losses and demand volatility, while remaining structurally positive on Astral over Supreme.
29 Jun 2026 09:00 AM
Astral: JPMorgan on Astral Downgrade to Neutral, citing demerger uncertainty despite freeing the high-margin plumbing business for stronger capital allocation, potential pressure on paints & adhesives growth, near-term PVC price correction, inventory losses and demand volatility, while remaining structurally positive on Astral over Supreme.
Astral: Investec on Astral Buy, Target Price ₹1,710, citing the demerger creating Astral Chemie (India’s second-largest listed pure-play after Pidilite Industries), strong adhesives/construction chemicals growth, healthy cash flow and RoCE, with enhanced disclosures and execution offering value unlocking potential.
29 Jun 2026 09:00 AM
Astral: Investec on Astral Buy, Target Price ₹1,710, citing the demerger creating Astral Chemie (India’s second-largest listed pure-play after Pidilite Industries), strong adhesives/construction chemicals growth, healthy cash flow and RoCE, with enhanced disclosures and execution offering value unlocking potential.
Astral: CLSA on Astral Hold, Target Price ₹1,475, citing the chemicals business demerger (adhesives & paints) to improve management focus, execution and capital allocation, with limited near-term impact while growth acceleration and margin improvement remain key rerating triggers.
29 Jun 2026 09:01 AM
Astral: CLSA on Astral Hold, Target Price ₹1,475, citing the chemicals business demerger (adhesives & paints) to improve management focus, execution and capital allocation, with limited near-term impact while growth acceleration and margin improvement remain key rerating triggers.
Astral: Investec maintains a Buy on Astral Ltd with a Target Price of ₹1,710, citing its acquisition of 60% stake in DSS (speciality chemicals & advanced materials) as a strategic move to deepen backward integration, drive cost efficiencies, and create a scalable new growth vertical, alongside upside risks to estimates from CPVC integration benefits and DSS expansion potential, though revenue ramp-up visibility remains awaited.
12 Jun 2026 08:58 AM
Astral: Investec maintains a Buy on Astral Ltd with a Target Price of ₹1,710, citing its acquisition of 60% stake in DSS (speciality chemicals & advanced materials) as a strategic move to deepen backward integration, drive cost efficiencies, and create a scalable new growth vertical, alongside upside risks to estimates from CPVC integration benefits and DSS expansion potential, though revenue ramp-up visibility remains awaited.
Astral: Subsidiary Acquires 60% Stake in DSS LLP for ₹39.11 Crore, Growing Chemicals Operations
11 Jun 2026 04:50 PM
Astral: Subsidiary Acquires 60% Stake in DSS LLP for ₹39.11 Crore, Growing Chemicals Operations
Astral: CLSA maintains a Hold on Astral with a Target Price of ₹1475, citing in-line Q4 EBITDA but weaker PAT due to forex and tax impacts, strong 24% YoY piping volume growth indicating market share gains, robust piping margins offset by weaker adhesives performance, and awaiting further clarity on growth guidance, capacity expansion, new products, and overseas adhesives strategy.
19 May 2026 08:55 AM
Astral: CLSA maintains a Hold on Astral with a Target Price of ₹1475, citing in-line Q4 EBITDA but weaker PAT due to forex and tax impacts, strong 24% YoY piping volume growth indicating market share gains, robust piping margins offset by weaker adhesives performance, and awaiting further clarity on growth guidance, capacity expansion, new products, and overseas adhesives strategy.
Astral: Jefferies maintains a Hold on Astral with a Target Price of ₹1570, citing a Q4 profit beat with strong 24% YoY sales growth led by robust plumbing volumes and margin expansion, while adhesives margins contracted sharply due to likely VAM cost pressures despite healthy segment growth.
19 May 2026 08:55 AM
Astral: Jefferies maintains a Hold on Astral with a Target Price of ₹1570, citing a Q4 profit beat with strong 24% YoY sales growth led by robust plumbing volumes and margin expansion, while adhesives margins contracted sharply due to likely VAM cost pressures despite healthy segment growth.
ASTRAL: Q4 CONS NET PROFIT 2.1B RUPEES VS 1.8B (YOY) || Q4 REVENUE 21B RUPEES VS 16.8B (YOY)
18 May 2026 04:09 PM
ASTRAL: Q4 CONS NET PROFIT 2.1B RUPEES VS 1.8B (YOY) || Q4 REVENUE 21B RUPEES VS 16.8B (YOY)
ASTRAL: Q4 EBITDA 3.8B RUPEES VS 3.02B (YOY) || Q4 EBITDA MARGIN 18.33% VS 17.96% (YOY)
18 May 2026 04:09 PM
ASTRAL: Q4 EBITDA 3.8B RUPEES VS 3.02B (YOY) || Q4 EBITDA MARGIN 18.33% VS 17.96% (YOY)
Astral: Today At 3pm MSCI February Rejig Stock To See Borderline Exclusion Of USD 161M (Rs 14.7B)
27 Feb 2026 11:24 AM
Astral: Today At 3pm MSCI February Rejig Stock To See Borderline Exclusion Of USD 161M (Rs 14.7B)
Astral: Morgan Stanley stays neutral on Astral, maintains Equal Weight with target price at ₹1,461
06 Feb 2026 09:02 AM
Astral: Morgan Stanley stays neutral on Astral, maintains Equal Weight with target price at ₹1,461
ASTRAL: Q3 CONS NET PROFIT 1.1B RUPEES VS 1.14B (YOY); EST 1.28B
05 Feb 2026 04:19 PM
ASTRAL: Q3 CONS NET PROFIT 1.1B RUPEES VS 1.14B (YOY); EST 1.28B
ASTRAL: Q3 REVENUE 15.4B RUPEES VS 13.97B (YOY)
05 Feb 2026 04:19 PM
ASTRAL: Q3 REVENUE 15.4B RUPEES VS 13.97B (YOY)
